Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine

This study has been completed.
Indivior Inc.
Information provided by:
University of California, Los Angeles Identifier:
First received: May 14, 2008
Last updated: January 6, 2010
Last verified: November 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)